GENE ONLINE|News &
Opinion
Blog

2018-11-23| PartnerAsia-Pacific

Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 2 Program

by Rajaneesh K. Gopinath
Share To
MEDTEX1200
Med X Tech Summit Asia

By Rajaneesh K. Gopinath, Ph.D.

Proudly co-organized by GeneOnline, the global biotech conference brings key opinion leaders comprising healthcare professionals and technology giants under one roof promoting scientific exchange and business partnerships. The event is to be held from Nov 29 – 30, 2018 at the Grande Luxe Banquet, Taipei, Taiwan.

The second day of MEDTEX 2018 boasts of two sessions, a morning session that covers expert panel discussions on state-of-the-art technologies in health security systems followed by lunch and a post lunch session on Global healthcare innovation strategy.

The following are some of the major highlights on the second day of the conference.

1) The inaugural panel discussion would focus on the rapidly growing technology of Blockchain and Electronic Health Security in Healthcare. Moderated by Yuan Yao, Chief Data Scientist at PwC, the discussion includes Mohammed Tayeb (Medicalchain), Alexandra Tinsman (NEM Foundation) and Emma Hossack (Extensia) as speakers.

The second panel discussion is on the topic of “Designing an Intelligent Healthcare Ecosystem. It is moderated by Ted Chang, CTO of Quanta Computer. Panel speakers Keren Priyadarshini (Microsoft), David Hansen (CSIRO), Vitaly Herasevich (Mayo Clinic) and Daniel Tse (Google AI) will grace us with their insights.

2) The Luncheon will witness the Highlights on Singapore Biotechnology Ecosystem and Innovation. Yan-Lin Lye of Cambridge consultants will participate and moderate the discussion that also includes Whye-Kei Lye (Nanyang Technological University), Johnson Chen (CapBridge/ClearBridge) and Hsien-Hui Tong (SGInnovate).

3) Dr. Pan-Chyr Yang, VP of IBMI will deliver the opening remarks of the third and final session of Med x Tech Summit Asia 2018. This session is one of the key features of the event where panel discussions will be held on the topic of Global Healthcare Innovation Strategy. Major highlights of the Bioinnovation stadium include discussions from Markus Kalousek from Novartis and Yong-Hui Shi from Medtronic China Venture Fund. Their discussions are expected to provide valuable inputs on how to build healthcare innovation cluster and startup strategy and how potential candidates are evaluated. Another main attraction is the talk by Karin Mayer Rubinstein who will share with us, their latest technology from Israel Advanced Technology Industries (IATI). Besides, countries like Australia, USA, and UK will address their own unique biotechnology ecosystems. The event will be concluded with the awarding ceremony of National Innovation Award 2018.

MEDTEX and Taiwan Healthcare+ Expo strategically connects IT, biotech, pharmaceuticals, precision medicine and health management industries with global biomedical innovators. GeneOnline and co-organizers have carefully handpicked the key opinion leaders from diverse industry backgrounds to provide a wholesome learning experience for attendees about the latest technology and market trends in addition to fostering industry partnerships. Healthcare and business professionals must take advantage of this opportunity.

To register for the event, please visit

https://www.eventbrite.com/e/medtex-med-x-tech-summit-asia-2018-tickets-50897919046

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Novartis Shifts Gear To Phase 3 For Anti-Malaria Drug
2022-11-24
35% of Americans May Avoid Seeking Care Due to Concerns Over Healthcare Prices
2022-10-31
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!